Quan Capital

Quan Capital is a Shanghai-based venture capital firm investing in early- and later-stage biotechnology and life sciences companies across China, the United States and Europe. The firm focuses on biopharmaceutical therapeutics including oncology, immunology, cell therapy, RNA and inflammatory-disease platforms, and has led investments in companies such as NextCure.